Rawat Mohit 4
4 · Fusion Pharmaceuticals Inc. · Filed Sep 30, 2021
Insider Transaction Report
Form 4
Rawat Mohit
President and CBO
Transactions
- Award
Stock Option (Right to Buy)
2021-09-27+257,000→ 257,000 totalExercise: $8.26Exp: 2031-09-27→ Common Stock (257,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to this option shall vest and become exercisable on the first anniversary of the grant date and the remainder shall vest and become exercisable in 36 substantially equal monthly installments thereafter.